871
|
|
|
AT-rich interaction domain 5A |
MRF-1, MRF1, RP11-363D14 |
|
872
|
|
|
AT-rich interaction domain 5B |
DESRT, MRF-2, MRF2 |
Rheumatoid arthritis, Attention deficit hyperactivity disorder, Autoimmune disease, Autoimmune thyroid disease, B-cell acute lymphoblastic leukemia, Cannabis abuse, Adenoid cystic carcinoma, Basal cell carcinoma, Cardiovascular disease, Lymphoblastic leukemia, Cleft palate, Congenital retrognathism, Global developmental delay, Gout, Graves disease, Hearing loss, Heart failure, Hypothyroidism, Keratoconus, Schizophrenia, Squamous cell carcinoma, Substance abuse, Systemic lupus erythematosus, Thyroid disease, Diabetes mellitus type 2, VitiligoView all (11 more) |
873
|
|
|
Ariadne RBR E3 ubiquitin protein ligase 1 |
ARI, HARI, HHARI, UBCH7BP |
|
874
|
|
|
Ariadne RBR E3 ubiquitin protein ligase 2 |
ARI2, TRIAD1 |
|
875
|
|
|
ARF like GTPase 11 |
ARLTS1 |
|
876
|
|
|
ARF like GTPase 13A |
ARL13, dJ341D10.2 |
|
877
|
|
|
ARF like GTPase 13B |
ARL2L1, JBTS8 |
|
878
|
|
|
ARF like GTPase 14 |
ARF7 |
|
879
|
|
|
ARF like GTPase 14 effector protein |
ARF7EP, C11orf46, dJ299F11.1 |
|
880
|
|
|
ARF like GTPase 15 |
ARFRP2 |
Barrett esophagus, Cardiovascular disease, Coronary artery disease, Diabetes mellitus, Esophageal adenocarcinoma, Gout, Kidney disease, Metabolic syndrome, Migraine, Nonalcoholic fatty liver disease, Psychiatric disorders, Rheumatoid arthritis, Schizophrenia, Diabetes mellitus type 2, Upper aerodigestive tract neoplasm |